Your browser doesn't support javascript.
Medicinal Marijuana, Stress, Anxiety, and Depression: Primum non nocere
Missouri Medicine ; 117(5):406-411, 2020.
Article in English | ProQuest Central | ID: covidwho-2147290
ABSTRACT
Higher levels of stress are associated with an increased risk of substance use disorders (SUDs) and other mental health conditions like depression. Short and long term changes in mood, depression, and suicidality can begin during adolescence and exacerbate by teen marijuana use according to a recent study.4 This longitudinal cohort study of over 30 years found that cannabis use during adolescence is not a medicine, but is associated with both depression and suicidality in adult life. [...]they are vulnerable to adverse cannabis outcomes, including continued opioid use and the development of additional substance use disorders.5 Public "medicinal" opinions on hydroxychloroquine and actual FDA- quality studies of safety and efficacy in SARS COVID 196 or voting marijuana a medicine is quite different than proving in a prospective, random assignment, placebo-controlled double-blind studies. Learning to inhale drug vapors may be the gateway event worth additional study.13 Most of the public health attention has been focused on vaping THC and death or severe toxic effects on lung and pulmonary function.
Keywords
Search on Google
Collection: Databases of international organizations Database: ProQuest Central Language: English Journal: Missouri Medicine Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: ProQuest Central Language: English Journal: Missouri Medicine Year: 2020 Document Type: Article